Video
Dr. Chee on novel Optilume device for patients with recurrent anterior urethral stricture
Author(s):
Video Player is loading.
In this video, Justin Chee, MD, discusses the takeaways and further research of 2 studies he presented at the 2021 International Continence Society Meeting: “The Optilume urethral drug coated balloon for recurrent anterior urethral strictures: 3-year results from the ROBUST I Study,” and “A randomized controlled trial evaluating the Optilume urethral drug coated balloon vs endoscopic management for treatment of recurrent anterior urethral strictures.” Chee is a reconstructive urological surgeon at Murac Health, East Melbourne, Australia.
Related Videos
Matthew Galsky, MD, reacts to NIAGARA results, durvalumab approval for MIBC
Rana McKay, MD, on persistence and adherence to relugolix for prostate cancer
Timothy Lyon, MD, on recent change to outpatient complications metric in urology rankings
Neeraj Agarwal, MD, on talazoparib/enzalutamide efficacy by HRR gene mutation status
Jason Hafron, MD, considers the future for AI in urology
Sima Porten, MD, discusses the need to educate on the firefighter-bladder cancer link
Eugene Cone, MD, outlines potential impact of Expanded Access Program for rBCG
Investigators evaluate tamsulosin use in pediatric patients
Ruchika Talwar, MD, on how urologists can get involved in advocacy
Chad Ellimoottil, MD, on how urologists should approach telehealth in changing policy environment
Related Content
